BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2647 related articles for article (PubMed ID: 7709158)

  • 1. Radioimmunodetection of malignant solid tumours.
    Kairemo KJ; Liewendahl K
    Scand J Clin Lab Invest; 1994 Dec; 54(8):569-83. PubMed ID: 7709158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabelled monoclonal antibodies in clinical and surgical oncology: a review.
    Biassoni L; D'Andrea V; Biancari F; Santoni F; Dibra A; De Antoni E
    Panminerva Med; 1997 Mar; 39(1):46-52. PubMed ID: 9175421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-murine antibody response to mouse monoclonal antibodies in cancer patients.
    Sakahara H; Saga T; Onodera H; Yao Z; Nakamoto Y; Zhang M; Sato N; Nakada H; Yamashina I; Endo K; Konishi J
    Jpn J Cancer Res; 1997 Sep; 88(9):895-9. PubMed ID: 9369938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor.
    Crombet T; Torres O; Neninger E; Catalá M; Rodríguez N; Ramos M; Fernández E; Iznaga N; Pérez R; Lage A
    Cancer Biother Radiopharm; 2001 Feb; 16(1):93-102. PubMed ID: 11279803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of radioimmunodetection with other imaging methods in evaluating local relapses of colorectal carcinoma.
    Gasparini M; Buraggi GL; Regalia E; Maffioli L; Balzarini L; Gennari L
    Cancer; 1994 Feb; 73(3 Suppl):846-9. PubMed ID: 8306269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunodetection and radioimmunotherapy of malignant melanoma. A review.
    Liewendahl K; Pyrhönen S
    Acta Oncol; 1993; 32(7-8):717-21. PubMed ID: 8305217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection.
    Lotze MT; Carrasquillo JA; Weinstein JN; Bryant GJ; Perentesis P; Reynolds JC; Matis LA; Eger RR; Keenan AM; Hellström I
    Ann Surg; 1986 Sep; 204(3):223-35. PubMed ID: 3753057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
    Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoguided surgery: clinical experience with different monoclonal antibodies and methods.
    Di Carlo V; Stella M; De Nardi P; Fazio F
    Tumori; 1995; 81(3 Suppl):98-102. PubMed ID: 7571064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course of ovarian cancer patients under repeated stimulation of HAMA using MAb OC125 and B43.13.
    Baum RP; Noujaim AA; Nanci A; Moebus V; Hertel A; Niesen A; Donnerstag B; Sykes T; Boniface G; Hör G
    Hybridoma; 1993 Oct; 12(5):583-9. PubMed ID: 8300134
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody, MN-14.
    Sharkey RM; Goldenberg DM; Murthy S; Pinsky H; Vagg R; Pawlyk D; Siegel JA; Wong GY; Gascon P; Izon DO
    Cancer; 1993 Mar; 71(6):2082-96. PubMed ID: 8443758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunoscintigraphic detection of metastasis in malignant melanoma in the head and neck area].
    Rosanowski F; Briele B; Walther EK
    Laryngorhinootologie; 1994 Feb; 73(2):94-7. PubMed ID: 8161416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement by affinity chromatography on antiidiotypic monoclonal antibodies (MAbs) of immunoreactivity and in vivo targeting of radiolabelled anti-HMW-MAA MAb TP61.5 in nude mice bearing human melanoma lesions.
    Temponi M; Fawwaz RA; Kekish U; Wang TS; Ferrone S
    Int J Cancer; 1991 Oct; 49(4):624-30. PubMed ID: 1917164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of biotinylated monoclonal antibodies (B72.3 and F023C5) in patients with colorectal cancer.
    Mangili F; Stella M; Sassi I; Ferrara F; Paganelli G; De Nardi P; Cantaboni A
    Eur J Histochem; 1993; 37(1):53-7. PubMed ID: 7682868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions.
    Spendlove L; Li L; Potter V; Christiansen D; Loveland BE; Durrant LG
    Eur J Immunol; 2000 Oct; 30(10):2944-53. PubMed ID: 11069077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoscintigraphy with MAb B72.3 for preoperative detection of lymph node metastases of colorectal carcinoma].
    Mörschel M; Bockisch A; Junginger T
    Chirurg; 1995 May; 66(5):503-6. PubMed ID: 7607013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoscintigraphy of tumours: possibilities and limitations.
    Pimm MV; Perkins AC; Baldwin RW
    Behring Inst Mitt; 1984 May; (74):61-71. PubMed ID: 6332618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunodetection of ovarian cancer.
    Ahlström KR; Hietala SO; Stendahl U; Stigbrand T
    Acta Oncol; 1993; 32(7-8):729-34. PubMed ID: 8305219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the pretargeting approach to image and treat tumours.
    Patra M; Zarschler K; Pietzsch HJ; Stephan H; Gasser G
    Chem Soc Rev; 2016 Nov; 45(23):6415-6431. PubMed ID: 27722526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiotypic-anti-idiotypic antibody interactions in experimental radioimmunotargeting.
    Sandström P; Johansson A; Ullén A; Rathsman S; Riklund-Ahlström K; Stigbrand T
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3073s-3078s. PubMed ID: 10541346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 133.